发布: 2019年10月05日第9卷第19期 DOI: 10.21769/BioProtoc.3390 浏览次数: 7841
评审: David PaulGANG YUVanesa Olivares-Illana
Abstract
Factors implicated in the pathophysiology of intestinal inflammation include defects in intestinal epithelial barrier function, abnormal immune responses, and activities of the gut microbiota. Current agents used to treat human Inflammatory Bowels Disease (IBD), chronic inflammation of digestive tract, have serious side effects. In addition, most of these treatments target the damaging factors while not providing pro-healing factors that repair the damaged intestine. Here we provide a method to isolate, purify and characterize a specific population from ginger (ginger-derived nanoparticles: GDNPs 2) with anti-inflammatory activities. GDNPs 2 as a drug vehicle are a novel natural, nontoxic delivery system, which target the inflamed intestinal mucosa, blocks damaging factors while promoting pro-healing factors and could easily be developed for large-scale production aimed at the treatment of IBD.
Keywords: Ginger (生姜)Background
Efforts to develop new drug-based therapeutic approaches against Intestinal Bowel Disease (IBD) must overcome several challenges, including issues of delivery, potential off-target effects, safety, toxicity, large-scale production costs, and tissue specificity (Chen et al., 2017). We and other groups have recently demonstrated that artificially synthesized nanoparticles may be used to target low doses of drugs (e.g., siRNAs, proteins and peptides) to specific cell types or tissues (Xiao et al., 2017). However, the nanoparticles synthesized to date have two major limitations: i) each constituent of the synthesized nanoparticles must be examined for potential in vivo toxicity before clinical application; and ii) the production scale is limited. The use of nanoparticles derived from natural sources may overcome these limitations of synthetic nanoparticles. Here, we provide a safe and cost-effective sucrose gradient ultracentrifuge method to isolate, purify and characterize a specific population of nanoparticles from ginger (ginger-derived nanoparticles: GDNPs 2) with anti-inflammatory activities. GDNPs 2 enable encapsulation of various types of therapeutic agents such as DNA, RNA and antibodies. Loading therapeutic agents in ginger-derived nanolipids can be found in a separate publication (Zhang et al., 2017). GDNPs 2 represents a novel natural, nontoxic delivery system that targets the inflamed intestinal mucosa, blocks damaging factors while promoting healing factors and may easily be developed for large-scale production aimed at the treatment of IBD.
Materials and Reagents
Equipment
Procedure
文章信息
版权信息
© 2019 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Sung, J., Yang, C., Viennois, E., Zhang, M. and Merlin, D. (2019). Isolation, Purification, and Characterization of Ginger-derived Nanoparticles (GDNPs) from Ginger, Rhizome of Zingiber officinale. Bio-protocol 9(19): e3390. DOI: 10.21769/BioProtoc.3390.
分类
生物化学 > 其它化合物 > 可食用纳米颗粒
分子生物学 > 纳米颗粒 > 植物源纳米颗粒
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link